Professor William Rosenberg

william.rosenberg@nhs.net https://profiles.ucl.ac.uk/179-william-rosenberg

NIHR Senior Investigator Emeritus, Professor of Liver Diseases, UCL

HPRU 2020 - 2025

William Rosenberg is Professor of Liver Diseases at UCL and is interested in all aspects of viral hepatitis from basic virology and immunology, through clinical trials of diagnostic tests and treatments, to and the implementation of healthcare innovations. He has research and clinical experience working in each of these fields.

Assessing the burden and characterising blood-borne viruses (BBV) among underserved populations: Exploring methods to identify and characterise underserved populations

Featured

2020 - 2025: Reducing the burden of undiagnosed STIs and BBVs

Exploring methods for mapping and monitoring needle exchange (NEX)/opioid substitution therapy (OST) service provision

Featured

2020 - 2025: Reducing the burden of undiagnosed STIs and BBVs

Development and application of novel biomarkers for HBV

Featured

2020 - 2025: Improving the care and management of people with STIs and BBVs

Epidemiology and management of HBV infection in the UK

Featured

2020 - 2025: Improving the care and management of people with STIs and BBVs

Identifying factors resulting in poor treatment outcomes in patients infected with ‘rare’ HCV subtypes using whole genome sequencing (WGS)

Featured

2020 - 2025: Improving the care and management of people with STIs and BBVs

Genomic and phylo-epidemiological analysis of HCV diversity and antiviral resistance in the UK

Featured

2020 - 2025: Improving the care and management of people with STIs and BBVs

Mapping multi-morbidity in HIV infection

Featured

2020 - 2025: Improving the care and management of people with STIs and BBVs

Development of methods for monitoring HCV re-infection

Featured

2020 - 2025: Reducing the burden of undiagnosed STIs and BBVs

Professor William Rosenberg

Assessing the burden and characterising blood-borne viruses (BBV) among underserved populations: Exploring methods to identify and characterise underserved populations

Exploring methods for mapping and monitoring needle exchange (NEX)/opioid substitution therapy (OST) service provision

Development and application of novel biomarkers for HBV

Epidemiology and management of HBV infection in the UK

Identifying factors resulting in poor treatment outcomes in patients infected with ‘rare’ HCV subtypes using whole genome sequencing (WGS)

Genomic and phylo-epidemiological analysis of HCV diversity and antiviral resistance in the UK

Mapping multi-morbidity in HIV infection

Development of methods for monitoring HCV re-infection

Our partners